667 results on '"Recker R"'
Search Results
2. Bone architecture, bone material properties, and bone turnover in non-osteoporotic post-menopausal women with fragility fracture
3. Bone remodeling and bone matrix quality before and after menopause in healthy women
4. Implementing a fracture liaison service open model of care utilizing a cloud-based tool
5. Effect of Macroanatomic Bone Type and Estrogen Loss on Osteocyte Lacunar Properties in Healthy Adult Women
6. Bone matrix mineralization is preserved during early perimenopausal stage in healthy women: a paired biopsy study
7. Marrow adiposity assessed on transiliac crest biopsy samples correlates with noninvasive measurement of marrow adiposity by proton magnetic resonance spectroscopy (1H-MRS) at the spine but not the femur
8. Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US™
9. Bone safety with risedronate: histomorphometric studies at different dose levels and exposure
10. Relationship of Bone Mineralization Density Distribution (BMDD) in Cortical and Cancellous Bone Within the Iliac Crest of Healthy Premenopausal Women
11. Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies
12. Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients
13. Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
14. Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension
15. Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study
16. Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density
17. Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet
18. Disuse-related decline in trabecular bone structure
19. Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians
20. Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy
21. Association analyses of vitamin D-binding protein gene with compression strength index variation in Caucasian nuclear families
22. Genome-wide association analyses suggested a novel mechanism for smoking behavior regulated by IL15
23. Comparison of whole genome linkage scans in premenopausal and postmenopausal women: no bone-loss-specific QTLs were implicated
24. Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results
25. A whole genome linkage scan for QTLs underlying peak bone mineral density
26. Effects of Treatment of Ovariectomized Adult Rhesus Monkeys with Parathyroid Hormone 1-84 for 16 Months on Trabecular and Cortical Bone Structure and Biomechanical Properties of the Proximal Femur
27. Correlation of transmenopausal bone mass in healthy white women: a long-term longitudinal study
28. Daily Treatment of Aged Ovariectomized Rats with Human Parathyroid Hormone (1-84) for 12 Months Reverses Bone Loss and Enhances Trabecular and Cortical Bone Strength
29. Genetic and Environmental Correlations of Bone Mineral Density at Different Skeletal Sites in Females and Males
30. Soy Isoflavones May Protect Against Orchidectomy-Induced Bone Loss in Aged Male Rats
31. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study
32. A Second-Stage Genome Scan for QTLs Influencing BMD Variation
33. Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study
34. Gene expression studies of osteoporosis: implications for microarray research
35. The Impact of Lifestyle Factors on Stress Fractures in Female Army Recruits
36. Genetic Variations in Bone Density, Histomorphometry, and Strength in Mice
37. Study Subjects and Ordinary Patients
38. Therapeutic equivalence of alendronate 70 mg onceweekly and alendronate 10 mg daily in the treatment of osteoporosis
39. ANKRD7 and CYTL1 are novel risk genes for alcohol drinking behavior
40. Bone Response to In Vivo Mechanical Loading in C3H/HeJ Mice
41. Association of VDR and Estrogen Receptor Genotypes with Bone Mass in Postmenopausal Caucasian Women: Different Conclusions with Different Analyses and the Implications
42. Urinary Calcium in Perimenopausal Women: Normative Values
43. The Association of Bone Mineral Density with Vitamin D Receptor Gene Polymorphisms
44. Bone Response to In Vivo Mechanical Loading in Two Breeds of Mice
45. Genomewide Linkage Scan for Combined Obesity Phenotypes using Principal Component Analysis
46. Caffeine does not affect the rate of gain in spine bone in young women
47. Prevalence and severity of vertebral fracture: The saunders county bone quality study
48. Association analysis of vitamin D-binding protein gene polymorphisms with variations of obesity-related traits in Caucasian nuclear families
49. Ultrasound, densitometry, and extraskeletal appendicular fracture risk factors: A cross-sectional report on The Saunders County Bone Quality Study
50. Transilial Bone Biopsy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.